Chronic Glucocorticoids Increase Hippocampal Vulnerability to Neurotoxicity under Conditions That Produce CA3 Dendritic Retraction But Fail to Impair Spatial Recognition Memory

Abstract

We previously found that chronic stress conditions producing CA3 dendritic retraction and spatial memory deficits make the hippocampus vulnerable to the neurotoxin ibotenic acid (IBO). The purpose of this study was to determine whether exposure to chronic corticosterone (CORT) under conditions that produce CA3 dendritic retraction would enhance CA3 susceptibility to IBO. Male Sprague Dawley rats were chronically treated for 21 d with CORT in drinking water (400 g/ml), and half were given daily injections of phenytoin (40 mg/kg), an antiepileptic drug that prevents CA3 dendritic retraction. Three days after treatments stopped, IBO was infused into the CA3 region. Conditions producing CA3 dendritic retraction (CORT and vehicle) exacerbated IBO-induced CA3 damage compared with conditions in which CA3 dendritic retraction was not observed (vehicle and vehicle, vehicle and phenytoin, CORT and phenytoin). Additionally, spatial recognition memory was assessed using the Y-maze, revealing that conditions producing CA3 dendritic retraction failed to impair spatial recognition memory. Furthermore, CORT levels in response to a potentially mild stressor (injection and Y-maze exposure) stayed at basal levels and failed to differ among key groups (vehicle and vehicle, CORT and vehicle, CORT and phenytoin), supporting the interpretations that CORT levels were unlikely to have been elevated during IBO infusion and that the neuroprotective actions of phenytoin were not through CORT alterations. These data are the first to show that conditions with prolonged glucocorticoid elevations leading to structural changes in hippocampal dendritic arbors can make the hippocampus vulnerable to neurotoxic challenges. These findings have significance for many disorders with elevated glucocorticoids that include depression, schizophrenia, Alzheimer's disease, and Cushing's disease.

Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers

“…Histological quantification, involving the measurement of CA3 or amygdala dendritric branch length for selected neurons, was performed with AxioVision 4.7 software and a Zeiss Imager M1 microscope. For each rat, total dendrite length was measured for amygdala neuron and separately for the apical branch and the basal sections of the CA3 neuron, as described by McLaughlin et al (2005) and Conrad et al (2007). We selected three to five hippocampal neurons per rat for measurement by an investigator blind to the origin of the experimental animal.…”

Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: Evidence that the duration of hormone deprivation after ovariectomy compromises 17β-estradiol effectiveness in altering CA1 spines

“…All brains were removed and processed at the same time (72 hours following the last injection). The staining procedure was the same as described previously by our lab (Bellani et al, 2006;Conrad et al, 2007;Kleen et al, 2006;McLaughlin et al, 2005;McLaughlin et al, 2007).…”

Endogenous and Exogenous Glucocorticoids Prevent Trimethyltin From Causing Neuronal Degeneration of the Mouse Brain In Vivo: Involvement of Oxidative Stress Pathways

“…Several lines of evidence indicate that prolonged elevation of glucocorticoid makes the hippocampus vulnerable to neurotoxic challenges (12,13). In addition to the finding that an acute treatment with TMT temporally increases the concentration of plasma corticosterone in rats (14), it has been demonstrated that a reduction in the level of circulating corticosterone by metyrapone, an inhibitor of corticosterone synthesis, prevents TMT from damaging the hippocampal neurons and eliciting learning impairment and hyperactivity in rats (15).…”